Atea Pharmaceuticals
AVIR
#7563
Rank
ยฃ0.21 B
Marketcap
ยฃ2.58
Share price
2.85%
Change (1 day)
12.82%
Change (1 year)

Revenue for Atea Pharmaceuticals (AVIR)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Atea Pharmaceuticals from 2020 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A
2022 N/A-100%
2021 ยฃ0.26 B629.57%
2020 ยฃ35.67 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA